In addition, although non-fasting blood glucose levels were steadily reduced by treatment with both xenin 18–25 and xenin 18–25 Gln, this failed to reach significance over the 21 day period ( Fig 3C , group: F = 2.521, p>0.05; time: F = 2.183, p<0.05; interaction: F = 0.1501, p>0.05).
← all excerpts
Biological Activity and Antidiabetic Potential of C-Terminal Octapeptide Fragments of the Gut-Derived Hormone Xenin.
1
0.0500
0.0500